Suv39h1 protects from myocardial ischemia-reperfusion injury in diabetic rats

Cellular Physiology and Biochemistry

Volumn 33, Issue 4, 2014, Pages 1176-1185

  Yang, Bo ^a   Yang, Jian ^b   Bai, Jing ^a   Pu, Peng ^c   Liu, Jun ^a   Wang, Fang ^a   Ruan, Bing ^a  

^a RENMIN HOSPITAL OF WUHAN UNIVERSITY   (China)

^b CHINA THREE GORGES UNIVERSITY   (China)

^c CHONGQING MEDICAL UNIVERSITY   (China)

Author keywords

Apoptosis; Diabetes; Inflammation; Ischemia reperfusion injury; Suv39h1

Indexed keywords

ADENOVIRUS VECTOR; HISTONE METHYLTRANSFERASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIPID; MITOGEN ACTIVATED PROTEIN KINASE; STREPTOZOCIN; SUV39H1; UNCLASSIFIED DRUG; METHYLTRANSFERASE; REPRESSOR PROTEIN; SUV39H1 PROTEIN, RAT; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; PROTEIN SUV39H1; STRESS ACTIVATED PROTEIN KINASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CARDITIS; CELL PROTECTION; CONTROLLED STUDY; CORONARY ARTERY OCCLUSION; CORONARY REPERFUSION; DIABETES MELLITUS; ENZYME ACTIVITY; GENE OVEREXPRESSION; GENETIC TRANSFECTION; HEART MUSCLE; HEART MUSCLE CELL; HEART MUSCLE ISCHEMIA; HEART PROTECTION; IMMUNOHISTOCHEMISTRY; LEFT CORONARY ARTERY; LIPID DIET; MALE; MORPHOMETRICS; NONHUMAN; PRIORITY JOURNAL; RAT; RAT MODEL; REAL TIME POLYMERASE CHAIN REACTION; REDUCTION; REPERFUSION INJURY; UPREGULATION; WESTERN BLOTTING; ADENOVIRIDAE; ANIMAL; COMPLICATION; EXPERIMENTAL DIABETES MELLITUS; GENE VECTOR; GENETICS; METABOLISM; PATHOLOGY; SIGNAL TRANSDUCTION; SPRAGUE DAWLEY RAT; ANTIINFLAMMATORY ACTIVITY; CARDIOVASCULAR GENE THERAPY; DRUG MECHANISM; EXPERIMENTAL CORONARY OCCLUSION; EXPERIMENTAL MYOCARDIAL ISCHEMIA; HEART INFARCTION SIZE; HEART INJURY; HUMAN; HUMAN CELL; STREPTOZOTOCIN-INDUCED DIABETES MELLITUS; VIRAL GENE DELIVERY SYSTEM;

ADENOVIRIDAE; RATTUS;

ADENOVIRIDAE; ANIMALS; APOPTOSIS; DIABETES MELLITUS, EXPERIMENTAL; GENETIC VECTORS; MALE; METHYLTRANSFERASES; MITOGEN-ACTIVATED PROTEIN KINASES; MYOCYTES, CARDIAC; NF-KAPPA B; RATS; RATS, SPRAGUE-DAWLEY; REPERFUSION INJURY; REPRESSOR PROTEINS; SIGNAL TRANSDUCTION; UP-REGULATION;

EID: 84898672363     PISSN: 10158987     EISSN: 14219778     Source Type: Journal    
DOI: 10.1159/000358686     Document Type: Article

References (27)

1. Yellon DM, Hausenloy DJ: Myocardial reperfusion injury. N Engl J Med 2007;357:1121-1135.
2. Heather LC, Clarke K: Metabolism, hypoxia and the diabetic heart. J Mol Cell Cardiol 2011;50:598-605.
3. Peake BF, Nicholson CK, Lambert JP, Hood RL, Amin H, Amin S, Calvert JW: Hydrogen sulfide preconditions the db/db diabetic mouse heart against ischemia-reperfusion injury by activating Nrf2 signaling in an Erk-dependent manner. Am J Physiol Heart Circ Physiol 2013;304:H1215-H1224.
4. Schnell O, Erbach M, Hummel M: Primary and secondary prevention of cardiovascular disease in diabetes with aspirin. Diab Vasc Dis Res 2012;9:245-255.
5. Stehouwer CD, Gall MA, Twisk JW, Knudsen E, Emeis JJ, Parving HH: Increased urinary albumin excretion, endothelial dysfunction, and chronic low-grade inflammation in type 2 diabetes: progressive, interrelated, and independently associated with risk of death. Diabetes 2002;51:1157-1165.
6. Evans JL, Goldfine ID, Maddux BA, Grodsky GM: Oxidative stress and stress-activated signaling pathways: a unifying hypothesis of type 2 diabetes. Endocr Rev 2002;23:599-622.
7. Kanter JE, Kramer F, Barnhart S, Averill MM, Vivekanandan-Giri A, Vickery T, Li LO, Becker L, Yuan W, Chait A, Braun KR, Potter-Perigo S, Sanda S, Wight TN, Pennathur S, Serhan CN, Heinecke JW, Coleman RA, Bornfeldt KE: Diabetes promotes an inflammatory macrophage phenotype and atherosclerosis through acyl-CoA synthetase 1. Proc Natl Acad Sci USA 2012;109:E715-E724.
8. La Bonte LR, Davis-Gorman G, Stahl GL, McDonagh PF: Complement inhibition reduces injury in the type 2 diabetic heart following ischemia and reperfusion. Am J Physiol Heart Circ Physiol. 2008; 294: H1282-H1290.
9. Marfella R, Siniscalchi M, Esposito K, Sellitto A, De Fanis U, Romano C, Portoghese M, Siciliano S, Nappo F, Sasso FC, Mininni N, Cacciapuoti F, Lucivero G, Giunta R, Verza M, Giugliano D: Effects of stress hyperglycemia on acute myocardial infarction: role of inflammatory immune process in functional cardiac outcome. Diabetes Care 2003;26:3129-3135.
10. Villeneuve LM, Natarajan R: The role of epigenetics in the pathology of diabetic complications. Am J Physiol Renal Physiol 2010;299:F14-F25.
11. Villeneuve LM, Reddy MA, Lanting LL, Wang M, Meng L, Natarajan R: Epigenetic histone H3 lysine 9 methylation in metabolic memory and inflammatory phenotype of vascular smooth muscle cells in diabetes.Proc Natl Acad Sci USA 2008;105:9047-9052.
12. Chen X, El Gazzar M, Yoza BK, McCall CE: The NF-kappaB factor RelB and histone H3 lysine methyltransferase G9a directly interact to generate epigenetic silencing in endotoxin tolerance. J Biol Chem 2009;284:27857-27865.
13. Martin C, Zhang Y: The diverse functions of histone lysine methylation. Nat Rev Mol Cell Biol 2005;6:838-849.
14. Zhou S, Chen HZ, Wan YZ, Zhang QJ, Wei YS, Huang S, Liu JJ, Lu YB, Zhang ZQ, Yang RF, Zhang R, Cai H, Liu DP, Liang CC: Repression of P66Shc expression by SIRT1 contributes to the prevention of hyperglycemia-induced endothelial dysfunction. Circ Res 2011;109:639-648.
15. Kim YR, Kim CS, Naqvi A, Kumar A, Kumar S, Hoffman TA, Irani K: Epigenetic upregulation of p66shc mediates low-density lipoprotein cholesterol-induced endothelial cell dysfunction. Am J Physiol Heart Circ Physiol 2012;303:H189-H196.
16. Uemura S, Matsushita H, Li W, Glassford AJ, Asagami T, Lee KH, Harrison DG, Tsao PS: Diabetes mellitus enhances vascular matrix metalloproteinase activity: role of oxidative stress. Circ Res 2001;88:1291-1298.
17. Suzuki K, Murtuza B, Smolenski RT, Sammut IA, Suzuki N, Kaneda Y, Yacoub MH: Overexpression of interleukin-1 receptor antagonist provides cardioprotection against ischemia-reperfusion injury associated with reduction in apoptosis. Circulation 2001;104:S I308-I3.
18. Aoyagi T, Kusakari Y, Xiao CY, Inouye BT, Takahashi M, Scherrer-Crosbie M, Rosenzweig A, Hara K, Matsui T: Cardiac mTOR protects the heart against ischemia-reperfusion injury. Am J Physiol Heart Circ Physiol 2012;303:H75-H85.
19. Armstrong SC: Protein kinase activation and myocardial ischemia/reperfusion injury. Cardiovasc Res 2004;61:427-436.
20. Ihnat MA, Thorpe JE, Ceriello A: Hypothesis: the 'metabolic memory', the new challenge of diabetes. Diabet Med 2007;24:582-586.
21. Brasacchio D, Okabe J, Tikellis C, Balcerczyk A, George P, Baker EK, Calkin AC, Brownlee M, Cooper ME, El-Osta A: Hyperglycemia induces a dynamic cooperativity of histone methylase and demethylase enzymes associated with gene-activating epigenetic marks that coexist on the lysine tail. Diabetes 2009;58:1229-1236.
22. ADVANCE Collaborative Group, Patel A, MacMahon S, Chalmers J, Neal B, Billot L, Woodward M, Marre M, Cooper M, Glasziou P, Grobbee D, Hamet P, Harrap S, Heller S, Liu L, Mancia G, Mogensen CE, Pan C, Poulter N, Rodgers A, Williams B, Bompoint S, de Galan BE, Joshi R, Travert F: Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med 2008;358:2560-2572.
23. Action to Control Cardiovascular Risk in Diabetes Study Group, Gerstein HC, Miller ME, Byington RP, Goff DC Jr, Bigger JT, Buse JB, Cushman WC, Genuth S, Ismail-Beigi F, Grimm RH Jr, Probstfield JL, Simons-Morton DG, Friedewald WT: Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med 2008;358:2545-2559.
24. Haunstetter A, Izumo S: Apoptosis: basic mechanisms and implications for cardiovascular disease. Circ Res 1998;82:1111-1129.
25. Zhao ZQ, Morris CD, Budde JM, Wang NP, Muraki S, Sun HY, Guyton RA: Inhibition of myocardial apoptosis reduces infarct size and improves regional contractile dysfunction during reperfusion. Cardiovasc Res 2003;59:132-142.
26. Gustafsson AB, Gottlieb RA: Bcl-2 family members and apoptosis, taken to heart. Am J Physiol Cell Physiol 2007;292:C45-C51.
27. Harwood SM, Yaqoob MM, Allen DA: Caspase and calpain function in cell death: bridging the gap between apoptosis and necrosis. Ann Clin Biochem 2005;42:415-431.